Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Veterinary Drugs
- Sub-Industry: N/A
- Symbol: NASDAQ:PAHC
- CUSIP: N/A
- Web: www.pahc.com
Capitalization:- Market Cap: $1.5301 billion
- Outstanding Shares: 39,641,000
Average Prices:- 50 Day Moving Avg: $36.94
- 200 Day Moving Avg: $31.35
- 52 Week Range: $19.02 - $39.00
P/E:- Trailing P/E Ratio: 23.98
- Foreward P/E Ratio: 24.65
- P/E Growth: 5.71
Sales & Book Value:- Annual Revenue: $758.62 million
- Price / Sales: 2.01
- Book Value: $3.52 per share
- Price / Book: 10.92
Dividend:- Annual Dividend: $0.40
- Dividend Yield: 1.0%
Profitability:- EBIDTA: $116.09 million
- Net Margins: 8.49%
- Return on Equity: 54.68%
- Return on Assets: 10.12%
Debt:- Debt-to-Equity Ratio: 2.20%
- Current Ratio: 3.27%
- Quick Ratio: 1.73%
Misc:- Average Volume: 151,027 shs.
- Beta: 1.35
- Short Ratio: 1.64
Frequently Asked Questions for Phibro Animal Health Corporation (NASDAQ:PAHC)
What is Phibro Animal Health Corporation's stock symbol?
Phibro Animal Health Corporation trades on the NASDAQ under the ticker symbol "PAHC."
How often does Phibro Animal Health Corporation pay dividends? What is the dividend yield for Phibro Animal Health Corporation?
Phibro Animal Health Corporation announced a quarterly dividend on Tuesday, July 25th. Stockholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share on Wednesday, September 27th. This represents a $0.40 annualized dividend and a dividend yield of 1.04%. The ex-dividend date is Friday, September 1st. View Phibro Animal Health Corporation's Dividend History.
How were Phibro Animal Health Corporation's earnings last quarter?
Phibro Animal Health Corporation (NASDAQ:PAHC) announced its quarterly earnings data on Monday, May, 8th. The company reported $0.37 EPS for the quarter, meeting the Zacks' consensus estimate of $0.37. The firm earned $190 million during the quarter, compared to analysts' expectations of $185.90 million. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. Phibro Animal Health Corporation's revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 EPS. View Phibro Animal Health Corporation's Earnings History.
When will Phibro Animal Health Corporation make its next earnings announcement?
What guidance has Phibro Animal Health Corporation issued on next quarter's earnings?
Phibro Animal Health Corporation updated its FY17 earnings guidance on Monday, May, 8th. The company provided earnings per share (EPS) guidance of $1.44-1.47 for the period, compared to the Thomson Reuters consensus estimate of $1.43. The company issued revenue guidance of $760-765 million, compared to the consensus revenue estimate of $757.20 million.
Where is Phibro Animal Health Corporation's stock going? Where will Phibro Animal Health Corporation's stock price be in 2017?
6 brokers have issued 1 year price objectives for Phibro Animal Health Corporation's stock. Their forecasts range from $21.00 to $36.00. On average, they anticipate Phibro Animal Health Corporation's share price to reach $29.00 in the next year. View Analyst Ratings for Phibro Animal Health Corporation.
What are analysts saying about Phibro Animal Health Corporation stock?
Here are some recent quotes from research analysts about Phibro Animal Health Corporation stock:
- 1. According to Zacks Investment Research, "Phibro ended third-quarter fiscal 2017 on a sluggish note, with earnings in line with the Zacks Consensus Estimate and declining year over year. Notably, the stock was trading below the Zacks categorized Medical Information Systems industry over the last three months. However post the earnings release the company’s share price shot up. This may be on account Phibro’s revenues increase on a year-over-year basis with Animal Health remaining the key contributing business. The company’s strong operating margin is also encouraging. Improved full-year earnings guidance is an upside too. On the flip side, additionally, currency fluctuations, sluggish macro-economic conditions and a tough competitive scenario are major concerns of the company. This fails to boost market confidence on the stock." (5/11/2017)
- 2. Piper Jaffray Companies analysts commented, "We continue to favor shares of PAHC as a top small cap idea in our ag space, where we see potential for upward revisions to guidance in 2H17 following the 2Q earnings beat and management reaffirming guidance. Positively, the Animal Health segment grew in the December-ending quarter despite ongoing headwinds in MFAs, supporting our thesis around the resilience of the animal health industry. We are lifting our FY17 EPS estimate to $1.45 at the top of the guidance range and we see potential earnings upside in 2H17 from growth outside of MFAs and in other geographies like Brazil. We see multiple expansion opportunity with some of the MFA overhang on the stock removed after the resilient 2Q results and our price target moves to $34 based on 21X FY18E EPS of $1.60. We reiterate our Overweight rating." (2/8/2017)
Who are some of Phibro Animal Health Corporation's key competitors?
Some companies that are related to Phibro Animal Health Corporation include INC Research Holdings (INCR), Ultragenyx Pharmaceutical (RARE), LivaNova PLC (LIVN), Wright Medical Group N.V. (WMGI), GW Pharmaceuticals PLC (GWPH), HealthEquity (HQY), Penumbra (PEN), Hutchison China MediTech Limited (HCM), BeiGene (BGNE), Agios Pharmaceuticals (AGIO), The Medicines Company (MDCO), China Biologic Products (CBPO), Intrexon Corporation (XON), Brookdale Senior Living (BKD), Ligand Pharmaceuticals Incorporated (LGND), Nevro Corp. (NVRO), LifePoint Health (LPNT) and Ironwood Pharmaceuticals (IRWD).
Who owns Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include
BFI COMPANY ., LLC
(51.80%), Spark Investment Management LLC (0.41%), Acadian Asset Management LLC (0.33%), Sit Investment Associates Inc. (0.38%), Bank of Montreal Can (0.14%) and Russell Investments Group Ltd. (0.10%). Company insiders that own Phibro Animal Health Corporation stock include Bfi Co, Llc, Daniel A Welch, Dean J Warras, E Thomas Corcoran, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger. View Institutional Ownership Trends for Phibro Animal Health Corporation.
Who sold Phibro Animal Health Corporation stock? Who is selling Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including Spark Investment Management LLC, OLD National Bancorp IN and Sit Investment Associates Inc.. Company insiders that have sold Phibro Animal Health Corporation stock in the last year include Bfi Co, Llc, Daniel A Welch, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Thomas G Dagger. View Insider Buying and Selling for Phibro Animal Health Corporation.
Who bought Phibro Animal Health Corporation stock? Who is buying Phibro Animal Health Corporation stock?
Phibro Animal Health Corporation's stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Strs Ohio, First Quadrant L P CA, Russell Investments Group Ltd., Bank of Montreal Can, Eqis Capital Management Inc., Campbell & CO Investment Adviser LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Phibro Animal Health Corporation.
How do I buy Phibro Animal Health Corporation stock?
Shares of Phibro Animal Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Phibro Animal Health Corporation's stock price today?
One share of Phibro Animal Health Corporation stock can currently be purchased for approximately $38.45.
MarketBeat Community Rating for Phibro Animal Health Corporation (NASDAQ PAHC)MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Phibro Animal Health Corporation (NASDAQ:PAHC) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Sell Ratings, 2 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $29.00 (24.58% downside) |
Analysts' Ratings History for Phibro Animal Health Corporation (NASDAQ:PAHC)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/21/2017 | Piper Jaffray Companies | Set Price Target | Buy | $35.00 | Low |  |
| 6/2/2017 | Credit Suisse Group | Downgrade | Outperform -> Neutral | $29.00 -> $36.00 | High | |
| 11/11/2016 | Macquarie | Downgrade | Neutral -> Underperform | $21.00 | N/A | |
| 11/10/2016 | Gabelli | Downgrade | Buy -> Hold | | N/A | |
| 9/12/2016 | Guggenheim | Set Price Target | Buy | $26.00 -> $30.00 | N/A | |
| 9/4/2016 | Morgan Stanley | Set Price Target | Sell | $23.00 | N/A | |
| 1/15/2016 | Barclays PLC | Downgrade | Overweight -> Underweight | $36.00 -> $31.00 | N/A | |
(Data available from 7/28/2015 forward)
Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)Earnings History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/30/2017 | | $0.36 | | | | | N/A | |
| 5/8/2017 | Q3 2017 | $0.37 | $0.37 | $185.90 million | $190.00 million | View | Listen | |
| 2/6/2017 | Q217 | $0.35 | $0.39 | $194.16 million | $192.00 million | View | Listen | |
| 11/9/2016 | Q1 2017 | $0.34 | $0.36 | $188.85 million | $188.00 million | View | Listen | |
| 8/29/2016 | Q416 | $0.38 | $0.40 | | $189.20 million | View | N/A | |
| 5/9/2016 | Q316 | $0.43 | $0.38 | $197.24 million | $183.00 million | View | N/A | |
| 2/9/2016 | Q216 | $0.41 | $0.39 | $198.27 million | $191.80 million | View | N/A | |
| 11/9/2015 | Q1 | $0.41 | $0.44 | $192.28 million | $187.10 million | View | N/A | |
| 9/9/2015 | Q415 | $0.38 | $0.44 | | $185.00 million | View | N/A | |
| 5/11/2015 | Q315 | $0.36 | $0.41 | $187.80 million | $187.50 million | View | N/A | |
| 2/10/2015 | Q215 | $0.36 | $0.35 | $181.52 million | $188.70 million | View | N/A | |
| 11/11/2014 | Q115 | $0.35 | $0.51 | $174.90 million | $187.50 million | View | N/A | |
| 9/16/2014 | Q414 | $0.27 | $0.22 | $175.90 million | $183.70 million | View | N/A | |
| 5/13/2014 | Q314 | $0.14 | $0.21 | $162.70 million | $173.30 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Phibro Animal Health Corporation (NASDAQ:PAHC)Current Year EPS Consensus Estimate: $1.45 EPS
Next Year EPS Consensus Estimate: $1.56 EPS
Current Dividend Information for Phibro Animal Health Corporation (NASDAQ:PAHC)| Next Dividend: | 9/27/2017 |
| Annual Dividend: | $0.40 |
| Dividend Yield: | 1.04% |
| Payout Ratio: | 24.69% (Trailing 12 Months of Earnings)
27.59% (Based on This Year's Estimates)
25.64% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Phibro Animal Health Corporation (NASDAQ PAHC)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/25/2017 | quarterly | $0.10 | 1.04% | 9/1/2017 | 9/6/2017 | 9/27/2017 |
| 5/9/2017 | Quarterly | $0.10 | 1.2% | 5/26/2017 | 5/31/2017 | 6/22/2017 |
| 2/7/2017 | quarterly | $0.10 | 1.37% | 2/27/2017 | 3/1/2017 | 3/22/2017 |
| 11/8/2016 | quarterly | $0.10 | 1.51% | 11/28/2016 | 11/30/2016 | 12/21/2016 |
| 7/26/2016 | quarterly | $0.10 | 1.95% | 9/2/2016 | 9/7/2016 | 9/28/2016 |
| 5/10/2016 | quarterly | $0.10 | 2.17% | 5/27/2016 | 6/1/2016 | 6/22/2016 |
| 2/9/2016 | quarterly | $0.10 | 1.18% | 2/29/2016 | 3/2/2016 | 3/23/2016 |
| 11/10/2015 | quarterly | $0.10 | 1.26% | 11/30/2015 | 12/2/2015 | 12/23/2015 |
| 7/28/2015 | quarterly | $0.10 | 1.08% | 8/31/2015 | 9/2/2015 | 9/23/2015 |
| 5/12/2015 | quarterly | $0.10 | 1.09% | 6/1/2015 | 6/3/2015 | 6/24/2015 |
| 2/10/2015 | quarterly | $0.10 | 1.43% | 3/2/2015 | 3/4/2015 | 3/25/2015 |
| 11/10/2014 | quarterly | $0.10 | 1.43% | 12/1/2014 | 12/3/2014 | 12/23/2014 |
| 7/28/2014 | quarterly | $0.10 | | 8/29/2014 | 9/3/2014 | 9/24/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Phibro Animal Health Corporation (NASDAQ:PAHC)Insider Ownership Percentage: 48.09%
Institutional Ownership Percentage: 47.21%
Insider Trades by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/6/2017 | Bfi Co., Llc | Major Shareholder | Sell | 16,000 | $36.00 | $576,000.00 | |
| 7/6/2017 | Jack Bendheim | Insider | Sell | 32,000 | $36.49 | $1,167,680.00 | |
| 7/5/2017 | Bfi Co., Llc | Major Shareholder | Sell | 16,000 | $36.98 | $591,680.00 | |
| 6/30/2017 | Bfi Co., Llc | Major Shareholder | Sell | 48,000 | $37.42 | $1,796,160.00 | |
| 6/23/2017 | Jack Bendheim | Insider | Sell | 48,000 | $37.15 | $1,783,200.00 | |
| 6/15/2017 | Bfi Co., Llc | Major Shareholder | Sell | 48,000 | $34.82 | $1,671,360.00 | |
| 6/9/2017 | Jack Bendheim | Insider | Sell | 48,000 | $35.62 | $1,709,760.00 | |
| 5/25/2017 | Jack Bendheim | Insider | Sell | 48,000 | $34.67 | $1,664,160.00 | |
| 5/19/2017 | Jack Bendheim | Insider | Sell | 48,000 | $34.15 | $1,639,200.00 | |
| 5/11/2017 | Gerald K Carlson | Director | Sell | 63,338 | $33.31 | $2,109,788.78 | |
| 5/10/2017 | Jack Bendheim | Insider | Sell | 1,400 | $34.04 | $47,656.00 | |
| 5/9/2017 | Larry Lee Miller | COO | Sell | 56,825 | $30.95 | $1,758,733.75 | |
| 5/9/2017 | Thomas G Dagger | SVP | Sell | 8,000 | $32.13 | $257,040.00 | |
| 5/4/2017 | Larry Lee Miller | COO | Sell | 18,953 | $30.13 | $571,053.89 | |
| 5/1/2017 | Larry Lee Miller | COO | Sell | 14,780 | $30.13 | $445,321.40 | |
| 3/20/2017 | Gerald K Carlson | Director | Sell | 12,000 | $28.13 | $337,560.00 | |
| 2/27/2017 | Gerald K Carlson | Director | Sell | 12,000 | $28.29 | $339,480.00 | |
| 2/16/2017 | Daniel A Welch | SVP | Sell | 5,000 | $29.55 | $147,750.00 | |
| 2/16/2017 | Larry Lee Miller | COO | Sell | 4,588 | $30.00 | $137,640.00 | |
| 2/15/2017 | Gerald K Carlson | Director | Sell | 12,000 | $29.77 | $357,240.00 | |
| 2/13/2017 | Larry Lee Miller | COO | Sell | 97,229 | $30.37 | $2,952,844.73 | |
| 1/4/2017 | Thomas G Dagger | SVP | Sell | 207 | $30.00 | $6,210.00 | |
| 1/3/2017 | Larry Lee Miller | COO | Sell | 187 | $30.00 | $5,610.00 | |
| 12/20/2016 | Larry Lee Miller | COO | Sell | 1,540 | $30.04 | $46,261.60 | |
| 12/20/2016 | Thomas G Dagger | SVP | Sell | 1,700 | $30.03 | $51,051.00 | |
| 12/19/2016 | Larry Lee Miller | COO | Sell | 252 | $30.00 | $7,560.00 | |
| 12/19/2016 | Thomas G Dagger | SVP | Sell | 200 | $30.01 | $6,002.00 | |
| 5/19/2016 | E Thomas Corcoran | Director | Buy | 5,000 | $18.14 | $90,700.00 | |
| 4/1/2016 | Gerald K Carlson | COO | Sell | 8,000 | $27.02 | $216,160.00 | |
| 2/19/2016 | Gerald K Carlson | COO | Sell | 8,000 | $28.09 | $224,720.00 | |
| 2/17/2016 | Bfi Co., Llc | Major Shareholder | Sell | 2,175 | $30.01 | $65,271.75 | |
| 2/10/2016 | Bfi Co., Llc | major shareholder | Sell | 3,400 | $30.78 | $104,652.00 | |
| 2/3/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.26 | $133,040.00 | |
| 2/3/2016 | Jack Bendheim | CEO | Sell | 12,000 | $33.39 | $400,680.00 | |
| 2/2/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.44 | $133,760.00 | |
| 2/1/2016 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $33.46 | $133,840.00 | |
| 2/1/2016 | Larry Lee Miller | President | Sell | 60,000 | $33.58 | $2,014,800.00 | |
| 1/29/2016 | Jack Bendheim | CEO | Sell | 39,944 | $32.10 | $1,282,202.40 | |
| 1/26/2016 | Daniel A. Welch | SVP | Sell | 3,000 | $32.05 | $96,150.00 | |
| 1/26/2016 | Gerald K. Carlson | COO | Sell | 12,923 | $32.13 | $415,215.99 | |
| 1/22/2016 | Larry Lee Miller | President | Sell | 51,225 | $30.07 | $1,540,335.75 | |
| 1/20/2016 | Gerald K. Carlson | COO | Sell | 8,000 | $29.27 | $234,160.00 | |
| 1/8/2016 | Larry Lee Miller | President | Sell | 4,303 | $30.03 | $129,219.09 | |
| 1/6/2016 | Bfi Co., Llc | major shareholder | Sell | 3,005 | $29.93 | $89,939.65 | |
| 1/6/2016 | Jack Bendheim | CEO | Sell | 8,056 | $30.01 | $241,760.56 | |
| 1/6/2016 | Larry Lee Miller | President | Sell | 4,472 | $30.10 | $134,607.20 | |
| 1/5/2016 | Bfi Co., Llc | major shareholder | Sell | 4,851 | $30.07 | $145,869.57 | |
| 1/4/2016 | Bfi Co., Llc | major shareholder | Sell | 200 | $29.92 | $5,984.00 | |
| 12/30/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.63 | $122,520.00 | |
| 12/30/2015 | Jack Bendheim | CEO | Sell | 12,000 | $30.49 | $365,880.00 | |
| 12/29/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.49 | $121,960.00 | |
| 12/28/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $30.34 | $121,360.00 | |
| 12/23/2015 | Gerald K. Carlson | COO | Sell | 2,006 | $32.03 | $64,252.18 | |
| 12/22/2015 | Gerald K. Carlson | COO | Sell | 1,071 | $32.02 | $34,293.42 | |
| 12/21/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $31.13 | $249,040.00 | |
| 12/18/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.83 | $381,960.00 | |
| 12/15/2015 | Larry Lee Miller | insider | Sell | 36,090 | $31.00 | $1,118,790.00 | |
| 12/14/2015 | Larry Lee Miller | insider | Sell | 23,910 | $30.74 | $734,993.40 | |
| 12/11/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.58 | $378,960.00 | |
| 12/3/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.63 | $391,560.00 | |
| 11/24/2015 | Gerald K. Carlson | COO | Sell | 16,000 | $32.08 | $513,280.00 | |
| 11/24/2015 | Thomas G. Dagger | SVP | Sell | 4,000 | $32.87 | $131,480.00 | |
| 11/18/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.68 | $126,720.00 | |
| 11/18/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.63 | $379,560.00 | |
| 11/17/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.71 | $126,840.00 | |
| 11/16/2015 | Bfi Co., Llc | major shareholder | Sell | 4,000 | $31.50 | $126,000.00 | |
| 11/12/2015 | Bfi Co., Llc | major shareholder | Sell | 12,000 | $32.21 | $386,520.00 | |
| 11/5/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.11 | $397,320.00 | |
| 10/30/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.21 | $398,520.00 | |
| 10/26/2015 | Gerald K. Carlson | COO | Sell | 7,900 | $32.15 | $253,985.00 | |
| 10/26/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.73 | $380,760.00 | |
| 10/21/2015 | Gerald K. Carlson | COO | Sell | 8,100 | $32.40 | $262,440.00 | |
| 10/16/2015 | Daniel A. Welch | SVP | Sell | 3,000 | $32.93 | $98,790.00 | |
| 10/16/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.10 | $385,200.00 | |
| 10/9/2015 | Jack Bendheim | CEO | Sell | 12,000 | $30.64 | $367,680.00 | |
| 10/1/2015 | Jack Bendheim | CEO | Sell | 12,000 | $31.44 | $377,280.00 | |
| 9/25/2015 | Jack Bendheim | CEO | Sell | 10,000 | $33.95 | $339,500.00 | |
| 9/23/2015 | Thomas G. Dagger | SVP | Sell | 4,000 | $34.76 | $139,040.00 | |
| 9/22/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $34.97 | $279,760.00 | |
| 9/21/2015 | Gerald K. Carlson | COO | Sell | 8,000 | $35.99 | $287,920.00 | |
| 9/18/2015 | Jack Bendheim | CEO | Sell | 18,000 | $35.90 | $646,200.00 | |
| 9/16/2015 | Dean J. Warras | insider | Sell | 4,000 | $34.73 | $138,920.00 | |
| 9/10/2015 | Jack Bendheim | CEO | Sell | 18,000 | $34.69 | $624,420.00 | |
| 9/3/2015 | Bfi Co., Llc | major shareholder | Sell | 16,900 | $35.08 | $592,852.00 | |
| 9/3/2015 | Jack Bendheim | CEO | Sell | 1,100 | $35.10 | $38,610.00 | |
| 8/28/2015 | Jack Bendheim | CEO | Sell | 18,000 | $34.89 | $628,020.00 | |
| 8/21/2015 | Gerald K. Carlson | COO | Sell | 16,000 | $35.04 | $560,640.00 | |
| 8/19/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $36.91 | $221,460.00 | |
| 8/19/2015 | Jack Bendheim | CEO | Sell | 18,000 | $37.14 | $668,520.00 | |
| 8/18/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $37.76 | $226,560.00 | |
| 8/17/2015 | Bfi Co., Llc | Major Shareholder | Sell | 6,000 | $36.76 | $220,560.00 | |
| 7/24/2015 | Jack Bendheim | CEO | Sell | 18,000 | $37.98 | $683,640.00 | |
| 7/21/2015 | Gerald K Carlson | COO | Sell | 8,000 | $37.97 | $303,760.00 | |
| 7/20/2015 | Gerald K Carlson | COO | Sell | 8,000 | $38.16 | $305,280.00 | |
| 7/15/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $38.13 | $686,340.00 | |
| 7/15/2015 | Jack Bendheim | CEO | Sell | 6,000 | $37.75 | $226,500.00 | |
| 7/14/2015 | Jack Bendheim | CEO | Sell | 6,000 | $38.25 | $229,500.00 | |
| 7/13/2015 | Jack Bendheim | CEO | Sell | 6,000 | $38.41 | $230,460.00 | |
| 7/9/2015 | Jack Bendheim | CEO | Sell | 18,000 | $36.90 | $664,200.00 | |
| 7/2/2015 | Bfi Co., Llc | Major Shareholder | Sell | 19,000 | $38.02 | $722,380.00 | |
| 6/26/2015 | Jack Bendheim | CEO | Sell | 36,000 | $36.37 | $1,309,320.00 | |
| 6/23/2015 | Gerald K Carlson | COO | Sell | 16,000 | $36.56 | $584,960.00 | |
| 6/22/2015 | Gerald K Carlson | COO | Sell | 8,000 | $36.47 | $291,760.00 | |
| 6/17/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $34.09 | $136,360.00 | |
| 6/17/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.13 | $397,560.00 | |
| 6/16/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $33.00 | $132,000.00 | |
| 6/15/2015 | Bfi Co., Llc | Major Shareholder | Sell | 4,000 | $32.31 | $129,240.00 | |
| 6/11/2015 | Jack Bendheim | CEO | Sell | 12,000 | $32.38 | $388,560.00 | |
| 6/4/2015 | Jack Bendheim | CEO | Sell | 12,000 | $33.68 | $404,160.00 | |
| 5/28/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $35.11 | $631,980.00 | |
| 5/21/2015 | Gerald K Carlson | COO | Sell | 16,000 | $35.62 | $569,920.00 | |
| 5/19/2015 | Bfi Co., Llc | Major Shareholder | Sell | 18,000 | $36.73 | $661,140.00 | |
| 5/18/2015 | Thomas G Dagger | SVP | Sell | 4,000 | $36.48 | $145,920.00 | |
| 12/19/2014 | Daniel A Welch | SVP | Sell | 4,000 | $29.20 | $116,800.00 | |
| 8/1/2014 | Bfi Co., Llc | Major Shareholder | Sell | 223,075 | $20.51 | $4,575,268.25 | |
| 4/22/2014 | E Thomas Corcoran | Director | Buy | 5,000 | $16.70 | $83,500.00 | |
| 4/16/2014 | Carol Wrenn | Director | Buy | 1,000 | $16.19 | $16,190.00 | |
| 4/16/2014 | L.P. Mayflower | Major Shareholder | Sell | 6,323,867 | $13.99 | $88,470,899.33 | |
(Data available from 1/1/2013 forward)
Headline Trends for Phibro Animal Health Corporation (NASDAQ:PAHC)
Latest Headlines for Phibro Animal Health Corporation (NASDAQ:PAHC)
| Source: |
|
| Date | Headline |
|---|
 | Phibro Animal Health Corporation (NASDAQ:PAHC) Declares $0.10 Quarterly Dividend
www.americanbankingnews.com - July 25 at 4:47 PM |
| Brokerages Expect Phibro Animal Health Corporation (PAHC) to Announce $0.36 EPS
www.americanbankingnews.com - July 21 at 10:18 PM |
| Phibro Animal Health Corporation (NASDAQ:PAHC) Stock Rating Reaffirmed by Piper Jaffray Companies
www.americanbankingnews.com - July 21 at 9:14 PM |
| Analyzing Phibro Animal Health Corporation (NASDAQ:PAHC) & Zoetis (ZTS)
www.americanbankingnews.com - July 12 at 8:18 AM |
| Phibro Animal Health Corporation (PAHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 11 at 12:20 AM |
| Insider Selling: Phibro Animal Health Corporation (PAHC) Major Shareholder Sells 16,000 Shares of Stock
www.americanbankingnews.com - July 7 at 10:43 PM |
| Phibro Animal Health Corporation (PAHC) Major Shareholder Sells $576,000.00 in Stock
www.americanbankingnews.com - July 7 at 10:43 PM |
| Jack Bendheim Sells 32,000 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) Stock
www.americanbankingnews.com - July 7 at 10:42 PM |
 | Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2017 Results
finance.yahoo.com - July 7 at 7:59 AM |
| Phibro Animal Health & Zydus Cadila Plan to Expand in India
finance.yahoo.com - July 7 at 7:59 AM |
 | Phibro Animal Health (PAHC) & Zydus Cadila to License Poultry Vaccine Technology
www.streetinsider.com - July 6 at 7:49 AM |
| Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro’s Poultry Vaccine Technologies
finance.yahoo.com - July 5 at 9:26 AM |
| Bfi Co., Llc Sells 48,000 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) Stock
www.americanbankingnews.com - June 30 at 10:30 PM |
| Phibro Animal Health Corporation (PAHC) vs. Zoetis (ZTS) Head to Head Survey
www.americanbankingnews.com - June 30 at 9:09 AM |
| Zacks: Analysts Anticipate Phibro Animal Health Corporation (PAHC) Will Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - June 27 at 6:20 PM |
| Insider Selling: Phibro Animal Health Corporation (PAHC) Insider Sells 48,000 Shares of Stock
www.americanbankingnews.com - June 23 at 10:34 PM |
| Phibro Animal Health Corporation (PAHC) Rating Increased to Strong-Buy at BidaskClub
www.americanbankingnews.com - June 22 at 6:04 PM |
 | How To YieldBoost Phibro Animal Health Corp. From 1.1% To 11.5% Using Options
www.thestreet.com - June 21 at 1:27 AM |
| ETFs with exposure to Phibro Animal Health Corp. : June 19, 2017
finance.yahoo.com - June 19 at 7:48 PM |
| Health Care Battle Rages On: 2 MedTech Stocks to Buy
finance.yahoo.com - June 16 at 8:40 AM |
| Phibro Animal Health Corporation (PAHC) Major Shareholder Bfi Co., Llc Sells 48,000 Shares
www.americanbankingnews.com - June 15 at 10:26 PM |
| Financial Comparison: Zoetis (ZTS) and Phibro Animal Health Corporation (PAHC)
www.americanbankingnews.com - June 15 at 10:17 AM |
| Phibro Animal Health Corporation (PAHC) Lowered to Buy at BidaskClub
www.americanbankingnews.com - June 14 at 5:58 PM |
| Phibro Animal Health Corporation (PAHC) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - June 14 at 12:46 AM |
| Phibro Animal Health (PAHC) Rides High on Solid Prospects
finance.yahoo.com - June 13 at 10:32 AM |
| Phibro Animal Health (PAHC) Up 10% Since Earnings Report: Can It Continue?
finance.yahoo.com - June 12 at 6:47 PM |
| Phibro Animal Health Corp (PAHC) Insider Sells $1,709,760.00 in Stock
www.americanbankingnews.com - June 9 at 10:08 PM |
| Phibro Animal Health Corp (PAHC) Stock Rating Lowered by Credit Suisse Group AG
www.americanbankingnews.com - June 2 at 11:58 AM |
| Phibro Animal Health Corp (PAHC) Expected to Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - June 1 at 4:22 PM |
| Phibro Animal Health Corp. : PAHC-US: Dividend Analysis : May 31st, 2017 (record date) : By the numbers : May 29, 2017
finance.yahoo.com - May 29 at 6:08 PM |
| Insider Selling: Phibro Animal Health Corp (PAHC) Insider Sells 48,000 Shares of Stock
www.americanbankingnews.com - May 25 at 10:21 PM |
 | Phibro Animal Health (PAHC) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 24 at 7:20 PM |
| Phibro Animal Health Corp Declares Quarterly Dividend of $0.10 (pahc)
www.americanbankingnews.com - May 21 at 11:50 AM |
| Phibro Animal Health Corp (PAHC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 20 at 12:12 AM |
| ETFs with exposure to Phibro Animal Health Corp. : May 16, 2017
finance.yahoo.com - May 16 at 6:50 PM |
| Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q3, 2017 By the Numbers : May 15, 2017
finance.yahoo.com - May 15 at 6:23 PM |
| Edited Transcript of PAHC earnings conference call or presentation 9-May-17 1:00pm GMT
finance.yahoo.com - May 14 at 10:49 AM |
| Phibro Animal Health Corp (PAHC) Insider Jack Bendheim Sells 1,400 Shares
www.americanbankingnews.com - May 12 at 10:50 PM |
| Phibro Animal Health Corp (PAHC) Director Gerald K. Carlson Sells 63,338 Shares
www.americanbankingnews.com - May 12 at 10:16 AM |
| Can The Uptrend Continue for Phibro Animal Health (PAHC)?
finance.yahoo.com - May 12 at 8:24 AM |
| Phibro Animal Health Corporation 2017 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 12 at 12:36 AM |
| Phibro Animal Health Corp (PAHC) SVP Thomas G. Dagger Sells 8,000 Shares
www.americanbankingnews.com - May 11 at 10:29 PM |
| Zacks Investment Research Upgrades Phibro Animal Health Corp (PAHC) to "Buy"
www.americanbankingnews.com - May 11 at 11:56 AM |
| Phibro Animal Health Corp (PAHC) COO Sells $1,758,733.75 in Stock
www.americanbankingnews.com - May 9 at 10:21 PM |
| Phibro Animal Health's (PAHC) CEO Jack Bendheim on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 6:43 PM |
| Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.3% Yield
www.streetinsider.com - May 9 at 11:15 AM |
 | Phibro Animal Health Corporation Reports Third Quarter
globenewswire.com - May 9 at 11:15 AM |
| Investor Network: Phibro Animal Health Corporation to Host Earnings Call
finance.yahoo.com - May 9 at 11:15 AM |
| Phibro Animal Health Corp (PAHC) Issues Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - May 8 at 9:24 PM |
| Phibro Animal Health Corp (PAHC) Issues FY17 Earnings Guidance
www.americanbankingnews.com - May 8 at 5:26 PM |
Phibro Animal Health Corporation (PAHC) Chart for Friday, July, 28, 2017
